Picture of Bio Path Holdings logo

BPTH — Bio Path Holdings News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Bio Path Holdings Inc reports results for the quarter ended in June - Earnings Summary

* Bio Path Holdings Inc  BPTH.OQ  reported a quarterly
adjusted
loss of 53 cents​​ per share for the quarter ended in June. The
lone analyst forecast for the quarter was for a loss of 52 cents
per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Bio Path Holdings Inc's reported EPS for the quarter was a
loss
of 53 cents​.
    * The mean earnings estimate of analysts had fallen by
about 18.2%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate 
    * Bio Path Holdings Inc shares had fallen by 75.9% this
quarter and lost 71.6% so far this year.
    * The company reported a quarterly loss of $4.23 million.
    * Wall Street's median 12-month price target for Bio Path
Holdings
Inc is $12.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 15 at 01:31 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.52          -0.53          Missed
 Mar. 31 2023      -0.45          -0.66          Missed
 Dec. 31 2022      -0.45          -0.52          Missed
 Sep. 30 2022      -0.45          -0.49          Missed

Recent news on Bio Path Holdings

See all news